Меню
Набор скоро начнётся NCT06614426

Surgical Treatment of Peri-implantitis Defects

Без фазы С лечением Peri Implantitis

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Test group 1 (T1), Test group 2 (T2), Control group (C).
Кому может быть актуально
Состояния в реестре: Peri Implantitis. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

The Efficacy of Electrolysis Decontamination with or Without Leukocyteplatelet Rich Fibrin (L-PRF) in the Surgical Treatment of Peri-implantitis Defects: a Randomized Controlled Trial

Обзор

The aim of this study is to evaluate the efficacy of implant surface decontamination using electrolysis cleaning system. And to evaluate the adjunctive use of L-PRF in promoting soft tissue healing and long-term stability of the peri-implant marginal bone in the surgical treatment of peri-implantitis.

Подробное описание

Research design

* Prospective, in which participants will be recruited and then followed up throughout a specified period of time. * Randomized, parallel designed, concurrent controlled trial with participants randomly allocated to either control or test groups. * Single-blinded as the outcome accessors will be blinded to the intervention.

Materials and Methods:

Patients attending Dubai Dental Hospital and requiring treatment of peri-implantitis will be invited to take part in this randomized controlled trial based on the following inclusion and exclusion criteria:

Inclusion criteria:

* Aged 18 or over. * Require treatment of peri-implantitis (defined as the presence of bleeding and/or suppuration on gentle probing, probing depths of ≥ 6 mm, presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling). * Screw retained implant crown. * Good compliance and commitment to attend follow-up review appointments. * Willing to provide informed consent.

Exclusion criteria

* History of surgical therapy of peri-implantitis. * Peri-implant defects indicated for regenerative procedure (i.e. contained bony defect). * Cement retained implant crown. * Systemic/local antibiotics during the previous 6 months. * Bone metabolic disease and/or taking medications that affect bone metabolism. * History of malignancy, radiotherapy or chemotherapy. * Pregnant or lactating women. * Smokers

The study will be conducted following the ethical standards of the Declaration of Helsinki in 1975, as revised in 2013 and the CONSORT statement will be used as a guideline in reporting this study.

Randomization, allocation concealment and blinding:

The participants will be randomly allocated to three equally sized groups using computer-generated numbers:

Control group (C): Conventional open flap debridement Test group 1 (T1): Open flap debridement using (GalvoSurge® - Straumann) Test group 2 (T2): Open flap debridement using (GalvoSurge® - Straumann) combined with L-PRF application

Вмешательства

  • Процедура Test group 1 (T1)
    Test group 1 (T1): Open flap debridement using electrolysis decontamination
  • Процедура Test group 2 (T2)
    Test group 2 (T2): Open flap debridement using electrolysis decontamination combined with L-PRF application
  • Процедура Control group (C)
    Conventional open flap debridement

Первичные конечные точки

  • Probing pocket depth [Срок оценки: Baseline (prior to surgical intervention), 3, 6, 12 and 24 months]
Вторичные конечные точки (4)
  • Presence or absence of plaque, bleeding on probing and suppuration [Срок оценки: Baseline (prior to surgical intervention), 3, 6, 12 and 24 months]
  • Peri-implant marginal bone level [Срок оценки: Baseline (prior to surgical intervention), 12 and 24 months]
  • Peri-implant soft tissue level [Срок оценки: Baseline (prior to surgical intervention), 3, 6, 12 and 24 months]
  • Peri-implant soft tissue thickness (Phenotype) [Срок оценки: Baseline (prior to surgical intervention), 3, 6, 12 and 24 months]

Критерии участия

Критерии включения

  • Aged 18 or over.
  • Require treatment of peri-implantitis (defined as the presence of bleeding and/or suppuration on gentle probing, probing depths of ≥ 6 mm, presence of bone loss beyond crestal bone level changes resulting from initial bone remodeling).
  • Screw retained implant crown.
  • Good compliance and commitment to attend follow-up review appointments.
  • Willing to provide informed consent.

Критерии исключения

  • History of surgical therapy of peri-implantitis.
  • Peri-implant defects indicated for regenerative procedure (i.e. contained bony defect).
  • Cement retained implant crown.
  • Systemic/local antibiotics during the previous 6 months.
  • Bone metabolic disease and/or taking medications that affect bone metabolism.
  • History of malignancy, radiotherapy or chemotherapy.
  • Pregnant or lactating women.
  • Smokers

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Двойное слепое
Основная цель
Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Публикации

  • Hamzacebi B, Oduncuoglu B, Alaaddinoglu EE. Treatment of Peri-implant Bone Defects with Platelet-Rich Fibrin. Int J Periodontics Restorative Dent. 2015 May-Jun;35(3):415-22. doi: 10.11607/prd.1861. PMID 25909530

Идентификаторы

NCT: NCT06614426 · MBRU IRB-2024-563

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗